Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Multi-sites, Randomized, Parallel, Controlled Clinical Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV Infection

NCT01824992 is registered in ClinicalTrials.gov with Lee's Pharmaceutical Limited as lead sponsor.

NCT NCT01824992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01824992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Multi-sites, Randomized, Parallel, Controlled Clinical Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV Infection
Lead sponsor
Lee's Pharmaceutical Limited
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2011
Completion date
September 30, 2012
Enrollment
325 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection